VEA Align; spineEOS
EOS imaging • Radiology • 06/25/2024
Device Purpose
VEA Align and spineEOS are cloud-based software systems designed to enhance orthopedic assessment and preoperative spine surgery planning. VEA Align employs a machine learning algorithm on 2D X-ray images for automated anatomical landmarking and global alignment analysis, providing data that can be utilized by spineEOS for detailed, patient-specific surgical strategy development.
Summary
VEA Align is a cloud-based software designed for orthopedic applications in pediatric (aged 7 years and older) and adult populations. It utilizes biplanar 2D X-ray images, exclusively from EOS imaging's systems, to display interactive anatomical landmarks. These landmarks are initially placed by a machine learning-based algorithm and can then be adjusted and validated by the user. The system aids healthcare professionals in assessing patient-specific global alignment and analyzing spinal deformities, degenerative diseases, and lower limb alignment disorders through precise angle and length measurements, with options to compare against published normative values. VEA Align can also export 3D datasets, and its AI algorithm for landmark placement was trained on over 10,000 X-ray images and validated for accuracy (median error ≤ 3 mm, 3rd quartile ≤ 5 mm) against ground truth data across diverse patient subgroups. spineEOS, also a cloud-based software, complements VEA Align by assisting healthcare professionals in preoperative planning for spine surgeries. It utilizes EOS images and their associated 3D datasets (which can be generated by VEA Align) along with clinical measurements to enable users to define patient-specific surgical strategies for adolescent and adult patients. spineEOS offers surgical planning tools for segmental alignment, interbody implants, osteotomy, spondylolisthesis, and rod curvature management. Both VEA Align and spineEOS require clinical judgment for appropriate use. Comprehensive nonclinical performance testing was conducted for both devices, including verification of design inputs, software and system integration, AI algorithm performance, as well as validation of multifunctional requirements, usability, and the accuracy of clinical parameter outputs.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. What is the quantified impact on surgical planning time or accuracy when using spineEOS with 3D datasets generated from VEA Align's AI-assisted landmarking versus manually generated datasets?; How does the performance of VEA Align's machine learning algorithm for landmark placement vary across different types or severities of spinal deformities not explicitly detailed in the subgroup analysis (e.g., very rare congenital conditions or severe post-traumatic deformities)?; What are the specific "published normative values" VEA Align uses for comparison, and how frequently are these values updated or validated for diverse demographic populations and evolving orthopedic standards?; Are there ongoing or planned clinical studies to evaluate the long-term clinical outcomes and patient-reported outcomes for patients whose surgical plans were developed using spineEOS, particularly concerning complex spinal reconstructions?; Given that VEA Align's AI algorithm is trained on EOS imaging system data, what are the specific technical challenges and retraining requirements anticipated for adapting it to utilize X-ray images from non-EOS imaging systems while maintaining comparable accuracy?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly